Skip to main content

GlaxoSmithKline and Sanofi sharing 'innovative technology' to develop COVID-19 vaccine

The Big Pharma companies expect to begin clinical trials for their adjuvanted vaccine candidate during the second half of 2020.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.